Novartis, Eisai Sue Rivals Over Planned Banzel Generics
Eisai Inc. and Novartis Pharma AG on Wednesday sued five generic-drug makers in Delaware federal court, alleging their rivals' planned versions of epilepsy treatment Banzel infringe three patents covering the drug....To view the full article, register now.
Already a subscriber? Click here to view full article